-
effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
December 01, 2015 - behaviors, and
most of these individuals report several hazardous alcohol use events yearly.8,9 Experts estimate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
November 01, 2012 - 1
Comparative Effectiveness Review
Number 86
Treatment for Restless Legs Syndrome
Executive Summary
Introduction
Restless legs syndrome (RLS) is a
neurological disorder characterized
by unpleasant sensations in the legs
and a distressing, irresistible urge to
move them. RLS can result in reduced
quality o…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
July 01, 2023 - EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review
1
Evidence-based Practice Center Rapid Response Protocol
Project Title: Making Healthcare Safer IV: Use of Report
Cards and Outcome Measurements to Improve the Safety of
Surgical Care
Review Questio…
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-non-muscle-invasive-bladder-cancer
November 01, 2020 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
May 01, 2013 - CER #9:
Comparative Effectiveness of Percutaneous Coronary
Interventions and Coronary Artery Bypass Grafting
for Coronary Artery Disease
Original release date:
October 2007
Surveillance Report:
May 2013
Key Findings:
- New RCT and cohort studies further delineate which
patients have improved outcome…
-
effectivehealthcare-admin.ahrq.gov/products/mhs4-surgical-report-cards/protocol
September 01, 2023 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-for-children-with-disruptive-behavior-disorders-dbds-including-oppositional-defiant-disorder-odd-conduct-disorder-cd-and-disruptive-behavior-disorder-not-otherwise-specified-dbd-nos-what-is-the-short-term-and-long-term-com
November 01, 2017 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/products/depression-brain-injury/research-protocol
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine/research-protocol
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/closing-quality-gap-summary_research.pdf
January 01, 2013 - According to an
estimate by the Centers for Disease Control and Prevention, in 2002 there were 1.7
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-topics_methods.pdf
January 01, 2010 - Fourth, estimate the potential value by
considering the probable impact on health of
commissioning
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
March 01, 2012 - Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension
Future Research Needs Paper
Number 14
Future Research Needs for
Angiotensin-Converting
Enzyme Inhibitors (ACEIs),
Angiotensin II Receptor…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Surgical, Inc., Palo Alto, CA) is a
ES-3
mobile medical platform intended to help clinicians estimate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
December 01, 2015 - Modeling
shows that the NS5A inhibitor daclatasvir has
two modes of action and yields a shorter estimate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-results-search-strategies-developed-with-without-text-mining-tools.pdf
March 01, 2021 - was an update (R5), while the others were de novo reviews, which may limit the utility
of the time estimate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/asthma-treatment_disposition-comments.pdf
September 10, 2012 - Disposition of Comments Report for Breathing Exercises and/or Retraining Techniques in the Treatment of Asthma: Comparative Effectiveness
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1251
Published Online: September 10, 2012
Comparativ…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
September 01, 2010 - for primary breast cancer and the magnitude of these risk factors.
13
For example, the
study will estimate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plant-based-treatments-draft-report-2025-rct-table-app-e.xlsx
January 01, 2025 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
March 01, 2012 - The
estimate of odds ratio across the studies ranged from
0.0877 to 0.58.65
Similarly, the reviewed … prevalence of total SBI ranging
from 10.8 percent45 to 19.4 percent.37 One of these
studies37 reported an estimate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
March 01, 2018 - Based on the results of studies found in ClinicalTrials.gov, we changed the estimate for the
effect … In this
project, we estimate that it took 10 to 45 minutes per additional eligible study identified.